Skip to main content
. 2021 May 25;4:100104. doi: 10.1016/j.jtauto.2021.100104

Fig. 1.

Fig. 1

The possible immunological mechanism to explain how interleukin-17 inhibitors can induce new onset inflammatory bowel disease. IFN, interferon; IL, interleukin; IL-17R, interleukin-17 receptor; TGF, transforming growth factor; TH17 cells, T helper 17 cells; TH1 cells, T helper 1 cells.